From Surf Wiki (app.surf) — the open knowledge base
HLA-DR16
HLA-DR16(DR16) is a HLA-DR serotype that recognizes the DRB1*1601, *1602 and *1604 gene products. DR16 is found in the Mediterranean at modest frequencies. DR16 is part of the older HLA-DR2 serotype group which also contains the similar HLA-DR15 antigens.
Alleles
Disease associations
DR16 is associated with Chaga's cardiomyopathy, rheumatic heart disease, coronary artery ectasia, and chronic discoid lupus erythematosus.
DRB1*1601 is associated with tuberculosis risk
DRB1*1602: Juvenile rheumatoid arthritis, rheumatic heart disease, Takayasu arteritis , systemic sclerosis (SSc) & anti-DNA topoisomerase I (anti-topo I) antibody, melioidosis (Burkholderia pseudomallei infection)
Extended linkage
DRB11601:DQA10102:DQB1*0502 haplotype is associated with tubeculousis risk
- 1602:DQA10102:DQB1*0502 haplotype: graves disease, cervical cancer (human papilloma virus infection), scleroderma
- 1602:DQA105:DQB1*0301 haplotype: rheumatic heart disease, systemic sclerosis
Genetic Linkage
| DRA | DRB1 | DRB5 | *0101 | *1601 | *0101 | DQA1 | bgcolor="#dddddd" | DQB1 | bgcolor="#dddddd" | DRB1 | HLA-A | bgcolor="#dddddd" | HLA-B | bgcolor="#dddddd" | DRB1 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Serotypes | |||||||||||||||||||
| DR16(2)-DR51 | |||||||||||||||||||
| *0101 | *1602 | *0101 | |||||||||||||||||
| *0101 | *1604 | *0101 | |||||||||||||||||
| DR16(2)-DQ5 (5.2, 1) | *0102 | *0502 | *1601 | ||||||||||||||||
| A2-B51(5)-DR16(2) | *0201 | *5101 | *1601 |
HLA-DR16 is genetically linked to HLA-DR51 and HLA-DQ5 serotypes.
References
References
- [http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]
- (2004). "MHC class I and class II genes in Mexican patients with Chagas disease.". Hum Immunol.
- (2003). "MHC class II alleles in Mexican patients with rheumatic heart disease.". Int J Cardiol.
- (2004). "HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia.". Acta Cardiol.
- (2007). "Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients". Clin. Exp. Dermatol..
- (2005). "Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: preliminary report.". Tuberculosis (Edinb).
- (2004). "HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos.". Hum Immunol.
- (2000). "Association of HLA-DRB11602 and DRB11001 with in Colombian mestizos as markers of Amerindian ancestry.". Int J Cardiol.
- (1999). "Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.". Arthritis Rheum.
- (1999). "HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).". Tissue Antigens.
- (1998). "HLA-DR and -DQ associations with melioidosis.". Hum Immunol.
- (2006). "The association between HLA class II haplotype with Graves' disease in Thai population.". Tissue Antigens.
- (2005). "Association of HLA-DR and -DQ genes with Graves disease in Koreans.". Hum Immunol.
- (2003). "HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.". Hum Immunol.
- (1996). "Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.". Arthritis Rheum.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about HLA-DR16 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report